Most Read Articles
Roshini Claire Anthony, 17 Jul 2018

Administering sodium thiosulfate 6 hours after cisplatin therapy almost halved the incidence of hearing loss in children with hepatoblastoma, according to results of the phase III SIOPEL 6* trial.

22 Jul 2018
In patients with advanced hepatitis C infections, taking direct-acting antivirals (DAAs) does not increase the risk of subsequent hepatocellular carcinoma (HCC), a recent study has shown.
02 Jul 2018
Resumption of warfarin at discharge following hospitalization for lower gastrointestinal bleeding (LGIB) is not associated with either 90-day or 6-month mortality, reports a study, adding that death in LGIB is primarily caused by age and comorbidities.
02 Jul 2018
Treating sleep apnoea/nocturnal hypoxia in children using continuous positive airway pressure (CPAP) appears to improve the severity of nonalcoholic fatty liver disease, according to a recent study.

Web-based intervention promotes weight loss among NAFLD patients

06 Nov 2018

A web-based intervention (WBI) yields similar weight-loss benefits for nonalcoholic fatty liver disease (NAFLD) patients as a traditional group-based intervention (GBI), a recent study has found.

The study included 716 consecutive NAFLD patients (mean age 51.6±12.8 years; 53.5 percent male; 33 percent with type 2 diabetes), of whom 438 received GBI meetings led by physicians, dietitians and psychologists. Those who could not attend GBIs were given a WBI (n=278), which involved interactive games, tests and online contact with the centre.

Participants in the WBI group showed a mean reduction of body mass index (BMI) by 3.4 percent at 6 months, 4.9 percent at 12 months and 5.5 percent at 24 months. The decline was statistically significant (p<0.001). Similar findings were reported for the GBI cohort (3.1 percent, 4.0 percent and 4.2 percent, respectively).

However, while BMI progressively dropped significantly in both groups, no significant between-group difference was observed (p=0.063).

Moreover, weight loss of >10 percent of the initial body weight at the 6-month follow-up was reported in 5 percent and 7 percent of the WBI and GBI groups, respectively. These proportions increased to 13 percent and 11 percent by month 12, and to 20 percent and 15 percent by month 24.

Attrition rates were also significantly higher in the WBI group. The number of cases continuously dropped to 76 percent, 58 percent and 43 percent at months 6, 12 and 24, respectively. In comparison, the corresponding retention rates in the GBI group were 87 percent, 80 percent and 69 percent (p<0.001).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Hepatology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 17 Jul 2018

Administering sodium thiosulfate 6 hours after cisplatin therapy almost halved the incidence of hearing loss in children with hepatoblastoma, according to results of the phase III SIOPEL 6* trial.

22 Jul 2018
In patients with advanced hepatitis C infections, taking direct-acting antivirals (DAAs) does not increase the risk of subsequent hepatocellular carcinoma (HCC), a recent study has shown.
02 Jul 2018
Resumption of warfarin at discharge following hospitalization for lower gastrointestinal bleeding (LGIB) is not associated with either 90-day or 6-month mortality, reports a study, adding that death in LGIB is primarily caused by age and comorbidities.
02 Jul 2018
Treating sleep apnoea/nocturnal hypoxia in children using continuous positive airway pressure (CPAP) appears to improve the severity of nonalcoholic fatty liver disease, according to a recent study.